Abstract

Shankar Lal Soni*, Munesh Kumari, Raju, Anil, Ashish Sharma and Akash Sharma

ABSTRACT

The ongoing creation of new viruses poses a serious threat to global health. Uncontrolled outbreaks can lead to pandemics, which can overwhelm our healthcare and economic systems. While vaccination is a traditional method for promoting herd immunity, antiviral vaccinations can only be used prophylactically and do little to treat patients who have already been infected. Virus infections were contracted. When vaccinations are unavailable in the early stages of a disease outbreak, therapeutic antiviral medicines can be employed as a stopgap measure. However, these medicines do not always work against new virus strains and sometimes have side effects that outweigh the advantages. Many of the obstacles that existing antiviral medicines face could be overcome by nanotechnology. Consider nano delivery Vehicles can be used to improve the pharmacokinetic profile of antiviral medicines while lowering systemic toxicity. Other unique nanomaterials with virucidal or virus-neutralizing characteristics can be used. In this review, we examine recent advances in antiviral nanotherapeutics and offer our thoughts on how nanotechnology can be used to combat the SARS-CoV-2 outbreak and future virus pandemics.